Iovance Biotherapeutics Inc (IOVA)

[GMH*]

Badger - was not thinking that at all. Just realized my original post was too wordy and my point was not clear. Fully agree that everyone's exit point, be it based on price or a catalyst, will be different. The only additional caution I would make is having the reason/catalyst for exit being a buyout. The problem with that is that no matter how high the SP goes, the rationale for holding persists. I have ridden too many stocks way up, but just held for that reason and ended up riding it all the way down and lower. If a BO happens, its all great, but have an idea of when the SP gets to high relative to its value. If an individual investor thinks its overvalued, a CEO with even deeper knowledge will certainly think so (especially wanting a good return for the acquiring company).

Sorry if I sound preachy... not my intent, but I have been told I can come off that way.